Skip to content
healthcare.dev
Get a free key

XELJANZ

NDC 0069-1001, tofacitinib, tablet, film coated, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-1001
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203214
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE5 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0069-1001-010006910010160 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cf74ba2f-afc5-4baa-8594-979c889a5831

  • NADAC price for package 00069100101

    GET /v1/drugs/nadac/00069100101

Use it

Look up 0069-1001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-1001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.